Episode 259 - Elegantly engineering therapies to fight cancer - Sarah Hein of March Biosciences

Sarah Hein is the co-founder and CEO of March Biosciences, a cancer-fighting cell therapy company that recently closed a $28.4 million series A round and is getting ready to launch its phase II trial. Sarah joins me today to discuss the past two and a half years of growing March and the role Houston and its biotech ecosystem has played in the company’s growth.